Royalty Pharma Reports First Quarter 2024 Results

Go back to Royalty Pharma Reports First Quarter 2024 Results
REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 58.75 -1.84 (3.04%)
Previous Close $60.59    52 Week High $3.48 
Open $60.44    52 Week Low $0.80 
Day High $60.71    P/E N/A 
Day Low $58.64    EPS $-1.54 
Volume 3,324,562